F901318 Single Ascending Dose Study in Healthy Male Volunteers

NCT02142153 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Invasive Aspergillosis

Interventions

DRUG: F901318
DRUG: Placebo

Sponsor

F2G Ltd

Collaborators

[object Object]